Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NanoDOX Hydrogel in Orthopedic Trauma Wounds
NCT01518491Phase 2Withdrawn
- Sponsor
- Nanoshift
- Start
- Apr 2012
- Primary completion
- Oct 2012
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline in Musculoskeletal injury, soft tissue wound, sponsored by Nanoshift. Planned start Apr 2012; status: withdrawn.
02
Drugs
doxycycline
03
Conditions
Musculoskeletal injurysoft tissue wound
Beyond the preview
Go deeper on NCT01518491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01518491.